Companies / Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc.

NYSE: DNACIK 1830214BOSTON, MAginkgo.bio

Financials · FY2025

Revenue$170.16M
Net income$-312.76M
Total debt
Cash$84.53M
Diluted EPS$-5.64
Shares outstanding67.3M

Ownership

67.3M shares outstanding · as of Jul 31, 2026
0.01%Insiders
Ownership
82.2%Class A
Share classes
Class A82.24%
Class B13.30%
Common Stock4.46%
Insiders0.01%9,099
10%+ / strategic3.55%2,391,649
Institutions45.41%30,577,242
Public float51.03%34,362,287

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 3

View all →
Insider% of sharesShares
Coen Steven P.See remarks
0.01%9,099
Sloan HarryDirector

Institutional holders 182

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 20, 2026Coen Steven P.
Executive
SellClass A Common Stock$8.7K-972
-10.46%
8,321
0.01% of shares
low
Mar 16, 2026Coen Steven P.
Executive
SellClass A Common Stock$4.8K-708
-7.22%
9,099
0.01% of shares
low
Jun 11, 2026Henry Christian O
Director
GrantRestricted Stock Units+25K
25,000
0.04% of shares
low
Jun 11, 2026Sloan Harry
Director
GrantRestricted Stock Units+25K
25,000
0.04% of shares
low
Mar 13, 2026Coen Steven P.
Executive
ExerciseRestricted Stock Units-312
-7.67%
3,755
<0.01% of shares
low
Mar 13, 2026Coen Steven P.
Executive
ExerciseRestricted Stock Units-1K
-12.48%
8,231
0.01% of shares
low
Mar 13, 2026Coen Steven P.
Executive
ExerciseClass A Common Stock+312
+3.29%
9,807
0.01% of shares
low
Mar 13, 2026Coen Steven P.
Executive
ExerciseClass A Common Stock+1K
+14.11%
9,495
0.01% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A0
BAILLIE GIFFORD &amp; COPassive13G/A2,391,649
Viking Global Investors LPPassive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
DNA37611X209